半夏秫米汤合栀子豉汤调控PINK1/Parkin信号通路介导线粒体自噬防治失眠伴抑郁的机制OA
Banxia Shumitang plus Zhizichi Tang Regulates PINK1/Parkin Signaling Pathway-mediated Mitochondrial Autophagy to Prevent and Treat Insomnia with Depression
目的:该研究探讨了半夏秫米汤合栀子豉汤(BZ)对失眠伴抑郁小鼠的作用及PTEN诱导的激酶1(PINK1)/帕金蛋白(Parkin)信号通路蛋白表达和线粒体自噬的影响.方法:将72只6周龄雄性昆明(KM)小鼠随机分为空白组,模型组,BZ低、中、高剂量组(BZ-L组、BZ-H组、BZ-H组,2.92、5.85、11.7 g·kg-1),艾司唑仑组(0.21 mg·kg-1),第1~3天制备失眠模型,模型组及给药组小鼠按400 mg·kg-1剂量腹腔注射对氯苯丙氨酸(PCPA),连续3 d,随后开始制备慢性不可预测温和应激(CUMS)经典抑郁模型,连续28 d,给药和造模同时进行,灌胃结束后进行24 h自主活动实验测试睡眠状态,糖水偏好实验、旷场实验评价其焦虑样状态,苏木素-伊红(HE)染色观察下丘脑组织形态学变化,尼氏染色观察尼氏体数量,透射电镜观察线粒体超微结构,线粒体膜电位JC-1检测线粒体功能,生化检测下丘脑中三磷酸腺苷(ATP)含量,免疫荧光检测活性氧(ROS)的表达,酶联免疫吸测定法(ELISA)检测血清中5-羟色胺(5-HT)、去甲肾上腺素(NE)、皮质醇(CORT)含量,蛋白免疫印迹法(Western blot)检测PINK1、Parkin、微管相关蛋白1轻链3(LC3)、隔离体蛋白1(p62)蛋白的表达水平,实时荧光定量聚合酶链式反应(Real-time PCR)检测PINK1、Parkin、LC3、p62 mRNA的表达水平.结果:24 h自主活动实验显示,与空白组比较,模型组小鼠自主活动时间不具有昼夜节律特征,与模型组比较,各治疗组小鼠具有明显昼夜节律特征(P<0.05);糖水偏好实验显示,与空白组比较,模型组糖水偏好率显著降低(P<0.01),与模型组比较,各治疗组糖水偏好率显著上升(P<0.01);旷场实验显示,与空白组比较,模型组小鼠的移动距离、平均速度、中央区频次、中央区停留时间显著下降(P<0.01),与模型组比较,各治疗组小鼠移动距离、平均速度、中央区频次、中央区停留时间明显增加(P<0.05,P<0.01);HE染色显示,与空白组比较,模型组下丘脑神经元细胞排列紊乱,细胞间隙较大,细胞核固缩较严重,与模型组比较,各治疗组下丘脑神经元损伤程度减轻;尼氏染色显示,与空白组比较,模型组神经元损伤程度加重,损伤细胞数量显著增加(P<0.01),与模型组比较,各治疗组损伤细胞数量显著减少(P<0.01);透射电镜显示,与空白组比较,模型组下丘脑线粒体肿胀破裂程度较重,胞质内可见明显的自噬溶酶体,与模型组比较,BZ-L组小鼠可见少量自噬溶酶体,其他治疗组线粒体肿胀破裂程度均得到缓解;ROS免疫荧光显示,与空白组比较,模型组线粒体ROS红色荧光强度显著增强(P<0.01);与模型组比较,各治疗组红色荧光强度显著降低(P<0.01);线粒体膜电位显示,与空白组比较,模型组小鼠线粒体膜电位显著下降(P<0.01),与模型组比较,各治疗组线粒体膜电位明显上升(P<0.05,P<0.01);生化检测显示,与空白组比较,模型组ATP含量显著降低(P<0.01),与模型组比较,各治疗组ATP表达量明显增加(P<0.05,P<0.01);ELISA显示,与空白组比较,模型组5-HT含量显著降低,NE、CORT含量显著上升(P<0.01),与模型组比较,各治疗组5-HT含量显著上升(P<0.01),NE含量显著降低(P<0.01),CORT含量明显降低(P<0.05,P<0.01);下丘脑Western blot显示,与空白组比较,模型组PINK1、Parkin、LC3的蛋白表达量显著下降(P<0.01),p62蛋白表达显著增加(P<0.01),与模型组比较,各治疗组PINK1的蛋白表达量明显上升(P<0.05,P<0.01),Parkin的蛋白表达量显著上升(P<0.01),p62蛋白表达明显降低(P<0.05,P<0.01),LC3蛋白含量明显增加(P<0.05,P<0.01);Real-time PCR显示,与空白组比较,模型组PINK1、Parkin、LC3 mRNA表达水平显著下降(P<0.01),p62 mRNA表达水平显著上升(P<0.01),与模型组比较,各治疗组PINK1、Parkin、LC3 mRNA表达量显著上升(P<0.01),p62 mRNA表达显著降低(P<0.01).结论:BZ可改善小鼠的失眠伴焦虑状态,其机制可能是通过调控PINK1/Parkin信号通路,改善线粒体功能,增强线粒体自噬,保护神经元及修复受损神经细胞以防治失眠伴抑郁.
Objective:To investigate the effect and mechanism of Banxia Shumitang plus Zhizichi Tang(BZ)on PTEN-induced kinase 1(PINK1)/Parkin signaling pathway in regulating mitochondrial autophagy in preventing insomnia with depression.Methods:Seventy-two 6-week-old male Kunming mice were randomized into a normal group,a model group,low-dose,medium-dose,and high-dose BZ groups(BZ-L,BZ-M,BZ-H,2.92,5.85,11.7 g·kg-1),and an estazolam(0.21 mg·kg-1)group.Insomnia model was established on days 1 to 3.p-Chlorophenylalanine(PCPA)was injected intraperitoneally at a dose of 400 mg·kg-1 into mice of the model group and administration groups for 3 consecutive days.Then,the classic depression model was established with chronic unpredictable mild stress(CUMS)for 28 consecutive days.Administration and modeling were performed simultaneously.After gavage,24 h spontaneous activity test was performed to test sleep state,and sugar preference test and open field test were performed to evaluate anxiety-like state.The morphological changes of the hypothalamus were observed by hematoxylin-eosin(HE)staining,and the number of Nissl bodies was observed by Nissl staining.The ultrastructure of mitochondria was observed by transmission electron microscopy.The mitochondrial membrane potential assay kit(JC-1)was used to examine the mitochondrial function,and a biochemical assay kit was used to measure the ATP content in the hypothalamus.The level of reactive oxygen species(ROS)was determined by the immunofluorescence assay,and the serum levels of 5-hydroxytryptamine(5-HT),noradrenalin(NE),and cortisol(CORT)were determined by enzyme-linked immunosorbent assay(ELISA).Western blot and Real-time quantitative polymerase chain reaction(Real-time PCR)were employed to determine the expression of PINK1,Parkin,microtubule-associated protein 1 light chain 3(LC3),and isolator protein 1(p62)at protein and mRNA levels,respectively.Results:The 24 h spontaneous activity test showed that compared with the normal group,the model group did not exhibit circadian rhythm characteristics in their spontaneous activity time,while the circadian rhythm characteristics were restored in each treatment group(P<0.05).The sucrose preference test indicated that compared with that in the normal group,the sucrose preference rate in the model group reduced(P<0.01),and compared with that in the model group,the sucrose preference rate in each treatment group increased(P<0.01).The open field test revealed that compared with the normal group,the model group exhibited decreased movement distance,average speed,frequency of visits to the central area,and time spent in the central area(P<0.01),and compared with those in the model group,these parameters in each treatment group increased(P<0.05,P<0.01).HE staining showed that compared with the normal group,the model group exhibited disarrangement of neurons in the hypothalamus,enlarged intercellular space,and severe nuclear condensation,while the degree of hypothalamic neuronal damage in each treatment group was alleviated.Nissl staining indicated that compared with the normal group,the model group demonstrated aggravated neuronal damage and increased damaged cells(P<0.01).Compared with that in the model group,the number of damaged cells in each treatment group decreased(P<0.01).Transmission electron microscopy showed that compared with the normal group,the model group exhibited mitochondrial swelling and rupture in the hypothalamus,with visible autophagic lysosomes in the cytoplasm.Compared with those in the model group,only a few autophagic lysosomes were observed in the BZ-L group,and the degree of mitochondrial swelling and rupture was alleviated in the other treatment groups.ROS immunofluorescence assay showed that compared with the normal group,the model group displayed enhanced red fluorescence intensity of mitochondrial ROS(P<0.01),which was attenuated in each treatment group(P<0.01).Mitochondrial membrane potential assay showed that compared with the normal group,the model group had declined mitochondrial membrane potential(P<0.01),which was recovered in each treatment group(P<0.05,P<0.01).The biochemical assay of ATP levels indicated that compared with the normal group,the model group exhibited decreased ATP content(P<0.01),which rebound in each treatment group(P<0.05,P<0.01).ELISA showed that compared with the normal group,the model group exhibited decreased 5-HT content and increased NE and CORT content(P<0.01).Compared with the model group,each treatment group showed increased 5-HT content(P<0.01)and reduced NE content(P<0.01)and CORT content(P<0.05,P<0.01).Western blot of the hypothalamus showed that compared with the normal group,the model group exhibited downregulated protein levels of PINK1,Parkin,and LC3(P<0.01)and upregulated protein level of p62(P<0.01).Compared with the model group,each treatment group showed upregulated protein levels of PINK1,Parkin,and LC3(P<0.05,P<0.01)and downregulated protein level of p62(P<0.05,P<0.01).Real-time PCR showed that compared with the normal group,the model group exhibited downregulated mRNA levels of PINK1,Parkin,and LC3(P<0.01)and upregulated mRNA level of p62(P<0.01).Compared with the model group,each treatment group showed upregulated mRNA levels of PINK1,Parkin,and LC3(P<0.01)and downregulated mRNA level of p62(P<0.01).Conclusion:BZ can ameliorate the insomnia and anxiety state of mice by regulating PINK1/Parkin signaling pathway to improve the mitochondrial function,enhance mitochondrial autophagy,protect neurons,and repair damaged nerve cells.
肖春凤;公佩帅;张旖旎;王平
湖北中医药大学 基础医学院,武汉 430070||湖北中医药大学 老年脑健康中医药防护技术与新产品研发教育部工程研究中心,武汉 430070湖北中医药大学 基础医学院,武汉 430070||湖北中医药大学 老年脑健康中医药防护技术与新产品研发教育部工程研究中心,武汉 430070湖北中医药大学 老年脑健康中医药防护技术与新产品研发教育部工程研究中心,武汉 430070||苏州市中医医院,江苏 苏州 215000湖北中医药大学 老年脑健康中医药防护技术与新产品研发教育部工程研究中心,武汉 430070||湖北时珍实验室,武汉 430070
医药卫生
失眠抑郁半夏秫米汤栀子豉汤PTEN诱导的激酶1(PINK1)/帕金蛋白(Parkin)信号通路线粒体自噬
insomniadepressionBanxia ShumitangZhizichi TangPTEN-induced kinase 1(PINK1)/Parkin signaling pathwaymitochondrial autophagy
《中国实验方剂学杂志》 2026 (20)
33-46,14
中医药传承与创新"百千万"人才工程(岐黄工程)——国家中医药领军人才支持计划项目(国中医药人教发[2018]12号)湖北省中央引领地方科技发展资金项目(2020ZYYD021)老年脑健康中医药防护技术与新产品研发教育部工程研究中心开放基金项目
评论